Viewing nowADMed Tablet 5 mg (Memantine Hydrochloride)
Memantine Hydrochloride 5mg
Tablet · Prescription medication
Korea Pharm Co., Ltd.

MFDS item code 202200176 · Approved 2022.01.11 · Insurance code 642803410
Treatment of moderate to severe Alzheimer's disease
This medication is used for the treatment of Alzheimer's disease from moderate to severe stages. It helps alleviate cognitive decline and slows the progression of symptoms to improve the quality of daily life.
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver is available to regularly check that the patient is taking the medicine. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed periodically. This medicine is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7): Administer 5mg once daily for 7 days. Week 2 (days 8-14): Administer 10mg once daily for 7 days. Week 3 (days 15-21): Administer 15mg once daily for 7 days. From week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. Older adults Based on clinical data, the recommended dose for older patients aged 65 years and over is 20mg once daily. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, administration of this medicine is not recommended.
This medication should not be administered to patients who are allergic to any of its components. It should also not be used in patients with severe liver dysfunction or very poor kidney function. This medication contains lactose; therefore, it should not be administered to patients with a genetic disorder that impairs the digestion of lactose. Patients with epilepsy or a history of seizures, or those at a high risk of seizures should use this medication with caution. Avoid concomitant use with specific medications to prevent severe side effects. Patients with changes in urine acidity or those who have recently suffered from heart problems should be carefully monitored while using this medication. While taking this medication, side effects such as dizziness, headaches, constipation, drowsiness, and increased blood pressure may occur, so caution is needed. This medication may interact with other drugs, particularly central nervous system drugs, blood pressure medications, and anticoagulants, so consult a doctor or pharmacist if taking these. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of this medication, and it is advisable to discontinue breastfeeding if nursing. The safety and efficacy of this medication in children and adolescents under 18 years have not been established. In case of overdose, central nervous system symptoms or gastrointestinal symptoms may arise, and immediate medical attention is required. This medication may reduce patient responsiveness, so special attention is needed when driving or operating machinery. Finally, keep out of reach of children and be cautious not to transfer the medication to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture exposure and should be kept at room temperature between 1 to 30 degrees Celsius. This will help maintain the drug's effectiveness and prevent degradation.
White round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 5mg
Tablet · Prescription medication
Korea Pharm Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.